Ricosprin 10 mg is an oral anticoagulant medication containing FDA-approved Rivaroxaban (10 mg) as the active ingredient. Rivaroxaban belongs to the Direct Oral Anticoagulant (DOAC) class of medications. It is a selective Factor Xa inhibitor that prevents blood clot formation.
USV Ltd manufactures this anticoagulant medication for various thromboembolic conditions. Factor Xa is a vital enzyme in the blood coagulation cascade (clotting process). By blocking Factor Xa, Rivaroxaban prevents fibrin formation and subsequent thrombus development.
The medication treats Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) and prevents clots in non-valvular Atrial Fibrillation. It also provides thromboprophylaxis (clot prevention) after orthopedic surgeries. Unlike Warfarin, it requires no routine INR monitoring (blood clotting time tests). Only periodic monitoring of hemoglobin and kidney function is advised.
Common side effects include hemorrhage (bleeding), ecchymosis (bruising), and gastrointestinal disturbances. Patients should avoid antiplatelet agents (blood-thinning medicines) and NSAIDs (pain relievers like Ibuprofen). Store tablets at room temperature in their original packaging.
Regularly monitoring hemoglobin levels (blood count) and renal function (kidney tests) is recommended. Immediate medical attention is required for major bleeding episodes or signs of hemorrhagic complications.
Ricosprin 10 mg provides adequate anticoagulation through a selective Factor Xa inhibition mechanism. Factor Xa converts prothrombin to thrombin (clotting protein) in the coagulation cascade. Blocking this enzyme prevents fibrin formation and subsequent thromboembolism (blood clot traveling through vessels).
Clinical applications include:
Rivaroxaban demonstrates a better safety profile than conventional Vitamin K antagonists (older blood thinners like Warfarin). It offers predictable pharmacokinetics (drug absorption and elimination) without food restrictions. The medication provides a rapid onset of action within 2-4 hours.
Patients benefit from fixed dosing without requiring frequent PT/INR monitoring (blood clotting tests). This improves medication adherence and reduces healthcare visits compared to traditional anticoagulant therapy.
This is a prescription medicine that needs careful medical care. Take it exactly as your doctor orders for the best results. Here are the general guidelines:
The strengths and substitutes available at Cheap Medicine Shop are:
| Ricosprin 15 Tablet | $8.10/10 tablets |
| Ricosprin 20 Tablet | $8.10/10 tablets |
This medicine is usually safe when used correctly. However, it may cause some problems, including:
These problems usually get better as your body gets used to the medicine. Call your doctor if bleeding doesn't stop or gets worse.
Liver disease
People with mild liver problems can usually take this medicine with close watching. Those with severe liver disease may need different treatment. Your doctor will do blood tests to check your liver health.
Kidney impairment
The kidneys help remove this medicine from the body. People with kidney problems may need smaller doses or different medications depending on severity. Regular kidney tests help keep you safe during treatment.
Pregnant and breastfeeding women
This medicine is not safe during pregnancy and may harm the baby. Women who can get pregnant should use birth control while taking it. Don't breastfeed while taking this medicine as it passes into breast milk.
Avoid
Don't take other blood thinners, Aspirin, or pain medicines like Ibuprofen unless your doctor says it's okay. Limit alcohol drinking as it increases the risk of bleeding. Be careful with activities that might cause injuries.
Rivaroxaban reaches peak plasma concentrations within 2-4 hours after oral administration. Therapeutic anticoagulation begins within this timeframe, providing immediate thromboembolic protection. For optimal efficacy, steady-state concentrations (stable drug levels) are achieved within 2-3 days of regular dosing.
Unlike Warfarin therapy, Rivaroxaban has minimal dietary interactions and restrictions for patients. However, avoid excessive alcohol consumption, which may increase bleeding risk significantly. Ask a doctor for more safety information.
Minor bleeding episodes like epistaxis (nosebleeds) or gingival bleeding (bleeding gums) are common but manageable. Apply direct pressure and seek medical advice if bleeding persists beyond the normal duration. Major bleeding requires immediate emergency medical intervention and possible reversal therapy.
No, concurrent use with Non-steroidal Anti-inflammatory Drugs (NSAIDs) significantly increases hemorrhagic risk and should be avoided. Acetaminophen (Paracetamol) is the preferred analgesic option during anticoagulant therapy. Always consult healthcare experts before adding any new medications to your treatment regimen.
Clinical monitoring focuses on the absence of thromboembolic events and assessment of bleeding complications. Healthcare providers evaluate symptom improvement and conduct periodic physical examinations. Laboratory monitoring of hemoglobin levels and renal function helps detect potential adverse effects during long-term therapy.